Ş. Çaǧlayan Et Al. , "Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.," Frontiers in pediatrics , vol.10, pp.942455, 2022
Çaǧlayan, Ş. Et Al. 2022. Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.. Frontiers in pediatrics , vol.10 , 942455.
Çaǧlayan, Ş., Sönmez, H. E., Otar Yener, G., Baǧlan, E., Öztürk, K., Ulu, K., ... Guliyeva, V.(2022). Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.. Frontiers in pediatrics , vol.10, 942455.
Çaǧlayan, Şengül Et Al. "Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.," Frontiers in pediatrics , vol.10, 942455, 2022
Çaǧlayan, Şengül Et Al. "Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.." Frontiers in pediatrics , vol.10, pp.942455, 2022
Çaǧlayan, Ş. Et Al. (2022) . "Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.." Frontiers in pediatrics , vol.10, p.942455.
@article{article, author={Şengül Çaǧlayan Et Al. }, title={Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19.}, journal={Frontiers in pediatrics}, year=2022, pages={942455} }